Etsuko Sekimoto

529 total citations
21 papers, 318 citations indexed

About

Etsuko Sekimoto is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Etsuko Sekimoto has authored 21 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Etsuko Sekimoto's work include Multiple Myeloma Research and Treatments (5 papers), Peptidase Inhibition and Analysis (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Etsuko Sekimoto is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Peptidase Inhibition and Analysis (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Etsuko Sekimoto collaborates with scholars based in Japan. Etsuko Sekimoto's co-authors include Hironobu Shibata, Shuji Ozaki, Masahiro Abe, Toshio Matsumoto, Toshihiro Hashimoto, Ken-ichi Kitazoe, Jin Asano, Tomoko Hara, Daisuke Inoue and Shinsuke Kido and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Etsuko Sekimoto

17 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Etsuko Sekimoto Japan 5 197 180 159 23 22 21 318
Clive Buckle United Kingdom 6 180 0.9× 125 0.7× 157 1.0× 22 1.0× 15 0.7× 9 279
Jin Asano Japan 4 215 1.1× 193 1.1× 157 1.0× 16 0.7× 11 0.5× 11 318
Yoshiaki Kuroda Japan 12 161 0.8× 222 1.2× 204 1.3× 34 1.5× 71 3.2× 36 403
E Martella Italy 4 128 0.6× 100 0.6× 97 0.6× 9 0.4× 20 0.9× 8 207
Elizabeth Budde United States 9 161 0.8× 88 0.5× 105 0.7× 30 1.3× 48 2.2× 26 275
Zvenyslava Husak Austria 7 108 0.5× 245 1.4× 83 0.5× 11 0.5× 51 2.3× 8 445
Sandra Bašić‐Kinda Croatia 11 87 0.4× 102 0.6× 96 0.6× 13 0.6× 29 1.3× 42 277
Magdalena Hinterbrandner Switzerland 6 145 0.7× 101 0.6× 105 0.7× 8 0.3× 117 5.3× 7 270
Pauline Huyghe France 4 121 0.6× 314 1.7× 262 1.6× 16 0.7× 20 0.9× 9 389

Countries citing papers authored by Etsuko Sekimoto

Since Specialization
Citations

This map shows the geographic impact of Etsuko Sekimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etsuko Sekimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etsuko Sekimoto more than expected).

Fields of papers citing papers by Etsuko Sekimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etsuko Sekimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etsuko Sekimoto. The network helps show where Etsuko Sekimoto may publish in the future.

Co-authorship network of co-authors of Etsuko Sekimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Etsuko Sekimoto. A scholar is included among the top collaborators of Etsuko Sekimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etsuko Sekimoto. Etsuko Sekimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ozaki, Shuji, et al.. (2023). Systemic osteosclerosis associated with primary bone marrow B‐cell lymphoma. SHILAP Revista de lepidopterología. 4(2). 483–487. 2 indexed citations
2.
3.
Sekimoto, Etsuko, et al.. (2022). [Clinical features of five cases of acquired factor V deficiency].. PubMed. 63(7). 733–739.
4.
Shigekiyo, Toshio, et al.. (2020). Cerebral infarction and iron deficiency anemia due to uterine myoma in two middle-aged women with histidine-rich glycoprotein deficiency. Thrombosis Research. 191. 30–33. 2 indexed citations
5.
6.
Ozaki, Shuji, Takeshi Harada, Etsuko Sekimoto, et al.. (2019). Polyclonal immunoglobulin recovery after autologous stem cell transplantation is an independent prognosis factor for survival in patients with multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(10). e215–e216. 1 indexed citations
7.
8.
Sekimoto, Etsuko, et al.. (2017). Hematopoietic neoplasms accompanied by severe enterocolitis due to Aeromonas species.. PubMed. 58(4). 303–308. 3 indexed citations
9.
Mori, Keiko, et al.. (2016). Diffuse large B-cell lymphoma recurring with zosteriform cutaneous lesions.. PubMed. 57(5). 602–7. 1 indexed citations
10.
Sekimoto, Etsuko, Hironobu Shibata, Keiko Mori, et al.. (2016). A Case of Diffuse Large B-cell Lymphoma Presented Epstein-Barr Virus Associated T-cell and B-cell Lymphoproliferative Disorders Followed by Autologous Peripheral Blood Stem Cell Transplantation. Nihon Naika Gakkai Zasshi. 105(7). 1275–1281. 1 indexed citations
11.
Shigekiyo, Toshio, Etsuko Sekimoto, Hironobu Shibata, et al.. (2015). Factor VII Tokushima. Blood Coagulation & Fibrinolysis. 26(8). 956–958. 1 indexed citations
12.
Shigekiyo, Toshio, et al.. (2014). Antithrombin-p.Ala416Pro: The Second Reported Case in Japan. Internal Medicine. 53(5). 477–481. 1 indexed citations
13.
Ozaki, Shuji, et al.. (2013). [Rapidly progressive AL amyloidosis in a patient with relapsed multiple myeloma after achieving a complete response to tandem autologous PBSCT].. PubMed. 54(12). 2171–6.
14.
Yamaguchi, Hiroshi, Etsuko Sekimoto, Hironobu Shibata, et al.. (2013). Testicular Nocardiosis Accompanied by Cutaneous Lesions in an Immunocompetent Man. Internal Medicine. 52(1). 129–133. 6 indexed citations
15.
Sekimoto, Etsuko, Shuji Ozaki, Takashi Ohshima, et al.. (2007). A Single-Chain Fv Diabody against Human Leukocyte Antigen-A Molecules Specifically Induces Myeloma Cell Death in the Bone Marrow Environment. Cancer Research. 67(3). 1184–1192. 20 indexed citations
16.
Oshima, Takashi, Masahiro Abe, Jin Asano, et al.. (2005). Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood. 106(9). 3160–3165. 256 indexed citations
17.
Ozaki, Shuji, Etsuko Sekimoto, Yoichi Tanaka, et al.. (2005). Anti-Myeloma Activity of the Maytansinoid Immunoconjugate of Internalizing Human Monoclonal Antibody Specific for HM1.24/BST2 (CD317).. Blood. 106(11). 3388–3388. 1 indexed citations
18.
Jalili, Ali, Shuji Ozaki, Tomoko Hara, et al.. (2004). Generation of HM1.24-Specific Cytotoxic T Lymphocytes from Peripheral Blood Stem Cell Harvests of Patients with Multiple Myeloma.. Blood. 104(11). 1487–1487. 1 indexed citations
19.
Oshima, Takashi, Masahiro Abe, Jin Asano, et al.. (2004). Myeloma Cells Suppress Osteoblast Differentiation by Secreting a Soluble Wnt Inhibitor, sFRP-2.. Blood. 104(11). 2356–2356. 6 indexed citations
20.
Ozaki, Shuji, Etsuko Sekimoto, Yoïchi Tanaka, et al.. (2004). Human Monoclonal Antibodies to TRAIL Receptors R1 and R2 Effectively Induce Apoptosis in Human Myeloma Cells.. Blood. 104(11). 3366–3366. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clive Buckle Breakdown of academic impact, for papers by Jin Asano Breakdown of academic impact, for papers by Yoshiaki Kuroda Breakdown of academic impact, for papers by E Martella Breakdown of academic impact, for papers by Elizabeth Budde Breakdown of academic impact, for papers by Zvenyslava Husak Breakdown of academic impact, for papers by Sandra Bašić‐Kinda Breakdown of academic impact, for papers by Magdalena Hinterbrandner Breakdown of academic impact, for papers by Pauline Huyghe
Rankless by CCL
2026